Wealthspire Advisors (Maryland)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$655K Buy
2,438
+454
+23% +$122K 0.02% 228
2020
Q2
$522K Sell
1,984
-114
-5% -$30.4K 0.04% 251
2020
Q1
$476K Sell
2,098
-9
-0.4% -$2.45K 0.04% 238
2019
Q4
$636K Buy
2,107
+61
+3% +$16.8K 0.04% 234
2019
Q3
$491K Sell
2,046
-5
-0.2% -$1.37K 0.04% 265
2019
Q2
$579K Buy
2,051
+12
+0.6% +$3.28K 0.04% 232
2019
Q1
$585K Buy
2,039
+1
+0% +$289 0.04% 227
2018
Q4
$535K Sell
2,038
-8
-0.4% -$2.2K 0.05% 209
2018
Q3
$561K Sell
2,046
-15
-0.7% -$3.89K 0.05% 228
2018
Q2
$491K Buy
2,061
+146
+8% +$33.8K 0.04% 241
2018
Q1
$421K Sell
1,915
-154
-7% -$36.2K 0.04% 282
2017
Q4
$466K Buy
2,069
+382
+23% +$81.4K 0.05% 267
2017
Q3
$320K Sell
1,687
-69
-4% -$13.1K 0.03% 345
2017
Q2
$330K Sell
1,756
-1,253
-42% -$225K 0.04% 324
2017
Q1
$498K Sell
3,009
-169
-5% -$26.9K 0.07% 185
2016
Q4
$457K Sell
3,178
-23
-0.7% -$3.08K 0.07% 188
2016
Q3
$401K Sell
3,201
-128
-4% -$16.5K 0.06% 209
2016
Q2
$437K Sell
3,329
-479
-13% -$65.5K 0.07% 185
2016
Q1
$529K Sell
3,808
-165
-4% -$22K 0.09% 147
2015
Q4
$554K Buy
+3,973
New +$547K 0.1% 140

Other funds holding ELV

Wealthspire Advisors (Maryland)'s ELV Position: Q3 2020 in Review

Wealthspire Advisors (Maryland) increased its Elevance Health (ELV) stake by 23% in Q3 2020, buying an estimated $122K and bringing the position to 2,438 shares worth $655K. The position accounts for 0.02% of the portfolio, ranked #228.

Wealthspire Advisors (Maryland) first reported a position in ELV in Q4 2015 and has held it in 20 quarters since. 1,094 funds tracked by Wall St. Rank hold ELV as of Q3 2020.

  • Wealthspire Advisors (Maryland) held 2,438 shares of Elevance Health worth $655K as of Q3 2020.
  • Wealthspire Advisors (Maryland) bought 454 Elevance Health shares in Q3 2020, an estimated $122K.
  • Elevance Health made up 0.02% of Wealthspire Advisors (Maryland)'s portfolio in Q3 2020, its #228 holding.
  • Wealthspire Advisors (Maryland) first reported a position in Elevance Health in Q4 2015 and has held it in 20 quarters since.
  • 1,094 funds tracked by Wall St. Rank held Elevance Health as of Q3 2020.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2020, filed 13 Nov 2020.